http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1706625-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc540243db37ec3c14fa4fa396322dee |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-07 |
| filingDate | 1990-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1992-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa274ada88b10f4c453b83197f9c3d59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_547641147c85f1d79f66a83226ff5de5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f5771b8c475b1c289f9315c9fbddb38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_220bbbb30c00bbb70013633a06533949 |
| publicationDate | 1992-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1706625-A1 |
| titleOfInvention | Method for forecasting retinoltherapy |
| abstract | The invention relates to medicine, in particular to vitamin therapy. The goal is to improve the accuracy of the prognosis while reducing the complications of therapy. To this end, plasma levels of retinol-binding protein are examined before and 5–48 hours after administration of a therapeutic dose of retinol, and with increasing levels of retinol-binding protein, the effectiveness of therapy is predicted. Treatment with retinol by the proposed method in 48 patients prevented the development of hypervitaminosis A in all patients. |
| priorityDate | 1990-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.